Soo Jin Choi Member of the 22ndNational Assembly Republic of Korea

Special Lecture : The Present and Future of Bio Ventures in the Republic of Korea

- Member of the 22ndNationalAssembly
- Member of the Science, ICT, Broadcasting and Communications Committee, National Assembly
- Senior Spokesperson, People Power Party (PPP)
- Professor by Special Appointment, Graduate School of Convergence Technology & Energy, Tech University of Korea
- CEO, Panolos Bioscience

Kyung SUN Director General, Korean ARPA-H Project

Key note Speech ①: Innovative and Bold research and development initiative in Biohealth

- Professor Emeritus, Korea University Medicine
- Special Professor, Kyung Hee University & Board of Trustee
- Co-chair, Medical Instrument Committee, Ministry of Food and Drug Safety
- President, Korean Society for Biomaterials
- President & CEO, Osong Medical Innovation Foundation
- Chair of Board, Korean Society for Thoracic and Cardiovascular Surgery
- President, Korean Society of Medical and Biological Engineering

Byung Geon (BG) Rhee GI Innovation, Chairman & CEO

Key note Speech ② : Strategy for Korea BioHealth Industry as Future Growth Engine

- Korea Support Committee for International Vaccine Institute
- Vice Chairman, CKD Pharm
- President and CEO, GC Corp
- Chairman, Korea Biotechnology Industry -Organization (BIO)
- Chairman, Council for Advanced Regenerative -Medicine (CARM)
- Ph,D.,Rice University U.S.
- B.S/M.S.,Seoul national University

Se-Woong Oh Vice President, Head of Research Institute, Yuhan Corporation

BIO Trend ① : : R&D open innovation strategy and a story of development of 3rd-generation EGFR inhibitor for NSCLC

- Member of the Investment Review Committee, Korea Drug Development Fund (KDDF)
- Head of Research Institute, Yuhan Corporation
- Member of R&D Policy Committee, Korea Pharmaceutical and Bio-Pharma Manufacturers Association
- Board of Director, Yuhan ANZ, Australia

Hae In Shin Vice President, Pipeline Value Up, SK Biopharmaceuticals

BIO Trend ② : Two Drugs, Two Different Journeys

- Biotech Investment, Venture Capital Team, SK Inc.
- Vice President, Business Development, SK Biopharmaceuticals
- Vice President, Pipeline Value Up, SK Biopharmaceuticals

Seung-kyou Lee Vice President of KoreaBIO

Discussion

- Vice President of KoreaBIO (2012 ∼ Present)
- CEO and founder of Bio Venture Company (2000 ∼ 2011)

Yeong Min Park President & CEO Korea Drug Development Fund

Discussion

- Professor, Department of Integrative Biological Sciences and Industry, Sejong University
- Member of National Academy of Medicine of Korea
- Director, Medical Research Center(MRC), Ministry of Science and ICT
- Director, Institute of Biomedical Sciences & Technology, Konkuk University
- Advisor/Founder/SAB(Chairman) of HLB Science

Aaron Seo Director General, Technology Company Listing Review, Korea Exchange

Key note Speech ③ : Guide to IPOs for Biotech companies

- MBA, UCLA
- BA, Seoul National Uni

Heesung Kim Director of Pre-Submission Consultation Division, Korea Ministry of Food and Drug Safety

BIO Trend ③ : Framework of Pre-Submission Consultation for Innovative Products

- APEC representative as Deputy Director of APEC harmonization center
- representative Deputy Director for ICH official member endorsement of MFDS

Joo Cheol Park CEO, HysensBio Co., Ltd.

IR Session

- CEO, HysensBio Co., Ltd., Gwacheon, Korea
- Professor, School of Dentistry, Seoul National University, Seoul, Korea
- Director, Dental Research Institute, Seoul National University
- Research Associate Professor, SUNY at Buffalo, NY, USA
- Postdoc, Okayama Medical School, Okayama, Japan

Seong-Wook Lee Rznomics Inc. / President & CEO

IR Session

- Central Pharmaceutical Affairs Advisory Committee, Ministry of Food Drug Safety, Committee Member
- Policy Review Committee of Advanced Regenerative Medicine and Advanced Biopharmaceuticals, Ministry of Health & Welfare. Advisory Committee Member
- Rznomics Inc. President & CEO
- Directorate for National Science and Engineering Programs, National Research Foundation of Korea. RP (R&D Planner)

Sung Kil Tak DOF Inc. CFO&COO

IR Session

- BioInfra Co., Ltd. CFO
- Team Leader, the Business Planning Team at WOORY Industrial Co., Ltd
- Deputy Team Leader, the Business Planning Team at WOOJIN Inc.
- Ajou University, Business Administration and English Literature

Myung Kee Kim CEO, LSK Investment

Discussion

- Fund manager, Intervest Global Pharma fund
- Managing Director, Intervest Co., LTD
- Board member, Korea Drug Development Fund
- Manager, Hansol Capital Investment Corporation
- Manager, Trigem Ventures

Soon ouk Jung Korea Investment Partners, Director

Discussion

- Korea Investment Partners, Director
- Industrial Bank of Korea / Sr. Analyst / Patent Attorney
- Melfas Inc. / Deputy Manager / Patent Attorney
- Central International Law Firm / Patent Attorney
- Daishin Securities

Young-Hun Lee Senior Director, LSK Investment Co., Ltd.

Discussion

- Director, Seven Tree Equity Partners Co., Ltd.
- Senior Manager, Medici Investment Co., Ltd.
- CMC Manger, Green Cross Research Center, GREEN CROSS CORP
- Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology
- Research Scientist, Dong-A Pharm. Co., Ltd. Research Laboratories